Carolina BioOncology Institute

01/26/2026

Due to the weather forecast, Carolina BioOncology will be closed for in-person visits on Monday, January 26 and Tuesday, January 27. In-person visits and infusions will resume on Wednesday, January 28, 2026.

Our team will be working remotely, and patients may call the clinic with questions or treatment-related side effects. For urgent or emergent concerns, please call 911 or go to the nearest emergency department.

Please stay safe!

01/26/2026

We appreciate the opportunity to connect with colleagues at Southern Oncology Specialists of Charlotte, where Dr. Neel Gandhi presented on advances in prostate cancer care as part of a continuing medical education session.

The discussion highlighted evolving treatment strategies, the potential benefit of early consideration of Phase I clinical trials, and emerging research, such as in circulating tumor cells for prostate cancer development.

Collaborative education strengthens patient access to innovative research and helps ensure patients are considered for clinical trials at the right time in their care journey.

01/22/2026

🎗️ Cervical Cancer Awareness February

In recognition of Cervical Cancer Awareness, here are important facts about Stage IV cervical cancer that highlight why continued research and innovation matter.

• About 13,000 invasive cervical cancers are diagnosed in the U.S. each year.
• Overall five-year cervical cancer survival is about 68 percent, and at Stage IV the five-year survival rate is approximately 20 percent.
These statistics show how critical it is to advance early detection, new treatment strategies, and clinical research across the spectrum of cervical cancer care.

At Carolina BioOncology Institute and BioCytics, we are committed to advancing cancer research that expands treatment options, improves outcomes, and supports patients at every stage of their journey.

12/27/2025

From all of us at Carolina BioOncology Institute, we wish our patients, families, caregivers, and community a peaceful holiday season and a hopeful new year. As we close out 2025, we honor the courage of everyone affected by cancer. Every act of strength and support brings us one step closer to a future free from this disease.

🌟 CBOI 2025: A Year of Impact
• Multiple Phase I clinical trial enrollments
• Inspiring patient milestones
• Collaborations with national research partners
• Celebrating 20 years of independent cancer research

We’re honored to serve patients seeking innovative treatment options, and we’re energized for 2026. Your resilience inspires us every day.

Here’s to another year of strength, discovery, and hope. 💙

12/24/2025

This month, we highlight Mr. Armistead's cancer journey. ✨ In March 2024, Armistead was diagnosed with pancreatic cancer and began chemotherapy. By July, the side effects were taking a significant toll on his life, limiting his time with his four sons, his ability to golf, and his enjoyment of sports events. With a prognosis of only eight months, Armistead’s hope was fading. But after researching alternative options and the national register for genetic markers and Phase 1 clinical trials, he self-referred to Carolina BioOncology Institute to explore potential treatments.

Armistead transitioned from chemotherapy to a Phase 1 clinical trial, and by August 2025, he was celebrating one year on investigational treatment. The results were life-changing, including a 56% reduction in tumor size from baseline, complete resolution of all three original lesions, and a dramatic decrease in his tumor markers.

Armistead reflects that moving from traditional chemotherapy to a clinical trial transformed his quality of life, providing more freedom, significantly fewer side effects, and a renewed sense of vitality. Today, he continues to thrive, surrounded by the love and support of his family. 💙His story is a powerful reminder of the life-changing potential that innovative research and clinical trials offer, instilling hope for many facing aggressive diseases.

12/18/2025

As the year comes to a close, we want to extend our gratitude to all the 2025 interns and shadowers who joined us this year, bringing their passion and curiosity to the fields of biotech, immunotherapy, and cell-based research.

Our interns had the unique opportunity to explore Phase I immuno-oncological clinical trials and gain firsthand experience in growing tumor cells and immune cells. They also received valuable exposure to the real-world operations of early-phase clinical research, which is essential for shaping the next generation of innovators.

We remain deeply committed to fostering education and mentorship in STEM, and we’re excited to continue this journey with future cohorts. We can’t wait to welcome the next group of bright minds eager to make an impact in the world of biotech and clinical research.

12/15/2025

Have you listened to TIL Talks yet? TIL Talks is a series, hosted by Chris White, featuring patient stories, expert insights, and conversations around innovations in cell and gene therapy.

In episode 18 (released October 7), Chris White welcomes Dr. John Powderly from Carolina BioOncology Institute to explore the latest advancements in immunotherapy research. They discuss the importance of empowering patients to actively seek clinical trials and highlight the critical role of nutrition and gut health in cancer treatment. The conversation also addresses the dangers of processed foods, synthetic additives, and environmental toxins, encouraging listeners to make healthier choices.

They further explore the benefits of regular exercise for cancer patients and the ongoing need for mental health support during the cancer journey. This episode also addresses survivorship topics including scan anxiety, community support, and the importance of long-term wellness for patients.

12/08/2025

November may be have ended, but awareness continues. 💜
Our team wore purple in recognition of Pancreatic, Gastric, Carcinoid, and Lung Cancer Awareness Month, a color symbolizing courage, survival, and honor for the patients and families impacted by these challenging diseases.

Fast Facts:
• Pancreatic Cancer is often diagnosed late due to subtle early symptoms, but advancements in targeted therapies and clinical research are steadily improving survival rates.
• Lung Cancer is the most common cancer worldwide, but immunotherapy is transforming treatment and offering new hope.
• Stage IV Gastric Cancer presents unique challenges due to its aggressive nature and late-stage diagnosis. However, emerging treatments, like targeted therapies and combination immunotherapy, are providing new avenues for survival and quality of life even in advanced stages.
• Carcinoid and Neuroendocrine Tumors are more prevalent than many realize and are often found incidentally during other treatments or exams.

At Carolina BioOncology Institute, we're dedicated to advancing Phase I clinical research and improving outcomes for patients facing these aggressive diseases. 💜

11/21/2025

11/15/2025

Last weekend, the Carolina BioOncology Institute and BioCytics team attended the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting, celebrating four decades of groundbreaking research and innovation in cancer immunotherapy.

We are proud to be part of a community driving forward the next generation of immune-based therapies through science, collaboration, and discovery.

10/31/2025

Happy Halloween from all of us at Carolina BioOncology Institute and BioCytics! 👻🎃

Our team took a break from clinical trials and research to celebrate with some spooky fun. Now we need your help, which costume deserves the win this year? Vote for your favorite costume in the comments below!

No tricks here, just smiles, treats, and a reminder of the amazing patients, colleagues, and community who inspire us every day. 💫

10/24/2025

During , we’re celebrating the vital role Medical Assistants play in advancing patient care at Carolina BioOncology Institute. Medical Assistants are essential in bridging clinical expertise and patient experience.

At Carolina BioOncology, we’re grateful for team members like Alexis and RJ, who bring compassion and excellence to every patient interaction. 💙